Healthcare 02 (May 15 - Dec 25)

[winston]

The 6 Best ETFs for Tapping Into Healthcare Stocks

Don't let the short-term pain in healthcare fool you. This is one sector you shouldn't bet against down the road.

By Aaron Levitt

Source: Investor Place

http://investorplace.com/2015/11/6-best ... lRTEnYrKM8

[winston]

Biotech fund IBB trends higher... shares jump double digits over the past month.

[winston]

Health care fund XLV rises 11% since late September.

[winston]

Beijing aims to refill medicine chest with 'Made in China' drugs

BY BEN HIRSCHLER AND ADAM JOURDAN

China is the world's second biggest drugs market behind the United States, and fast food, smoking and pollution, have fueled a rise in cancers and chronic heart and lung diseases.

The country also has more diabetics than any other in the world, with numbers expected to hit 151 million by 2040 from 110 million today, according to the International Diabetes Federation.

Source: Reuters

http://www.reuters.com/article/2015/11/ ... v9O0h66.99

[winston]

not vested

5 Big Pharma Stocks to Buy (And 2 Busts to Avoid!)

The men are being separated from the boys, so to speak, among pharmaceutical stocks

By James Brumley

Source: Investor Place

http://investorplace.com/2015/11/5-big- ... lzt5XYrKM8

[winston]

<Research Report>G Sachs Initiates Investment Ratings on Healthcare Industry (Table)

Goldman Sachs, in its report, listed the latest investment ratings and target prices for Chinese healthcare stocks:

Company Name (Stock Code)/ Investment Rating/ Target Price (HK$)
LUYE PHARMA (02186.HK)/ Buy (CL-Buy)/ 8.8
CSPC PHARMA (01093.HK)/ Buy/ 8.7
SINO BIOPHAR-1K (01177.HK)/ Buy/ 8.45
SH PHARMA (02607.HK)/ Neutral/ 19.85
CMS (00867.HK)/ Neutral/ 12.05
FOSUN PHARMA (02196.HK)/ Neutral/ 28.45
3SBIO (01530.HK)/Neutral/ 11.1
BAIYUNSHAN PH (00874.HK)/ Sell/ 19.7
SINOPHARM (01099.HK)/ Neutral/ 35.95
WEIGAO GROUP (01066.HK)/ Neutral/ 6.3

Source: AAStocks Financial News

[winston]

<Research Report>Citi's Latest TPs & Ratings for Chinese Pharmaceutical Stocks (Table)

Citigroup's latest target prices and ratings for Chinese pharmaceutical stocks:

Company Name (Stock Code)/ Rating/ Target Price (HK$)
SINOPHARM (01099.HK)/ Buy/ 38.8->43
SH PHARMA (02607.HK)/ Buy/ 31->24
SINO BIOPHAR-1K (01177.HK)/ Buy/ 6.67->8.6
CSPC PHARMA (01093.HK)/Buy/ 8.6
LUYE PHARMA (02186.HK)/ Buy/ 9.75
CMS (00867.HK)/Buy/ 12.3
FOSUN PHARMA (02196.HK)/Buy/ 38->32
LEE'S PHARM (00950.HK)/Buy/ 12.4->11
BAIYUNSHAN PH (00874.HK)/Buy/ 35.69->31
MICROPORT (00853.HK)/Buy/ 5.8->3.7
WEIGAO GROUP (01066.HK)/ Neutral/ 6.8
TONG REN TANG (01666.HK)/ Neutral/ 13
LIVZON PHARMA (01513.HK)/Buy/ 47.69

Source: AAStocks Financial News

[winston]

The Future of Medicine

By Marc Lichtenfeld

Source: The Oxford Club

http://wealthyretirement.com/future-of- ... ?src=email

[winston]

Biotech Continues to Offer Huge Returns for Investors

by Rachel Gearhart

Source: Investment U

http://www.investmentu.com/article/deta ... mTw8fkrKM8

[winston]

Jim Chanos is skeptical about health care stocks in 2016

by Akin Oyedele

Source: Business Insider

http://thecrux.com/jim-chanos-why-inves ... s-in-2016/